doi.org/10.1016/s1470-2045(20)30011-5

Camrelizumab in patients with previously treated advanced hepatocellular carcinoma: a multicentre, open-label, parallel-group, randomised, phase 2 trial

..., Weijia Fang
37
The Lancet Oncology35.90
Volume: 21, Issue: 4, Pages: 571 - 580
Published: Feb 26, 2020
Paper Fields
Paper Details
Title
Camrelizumab in patients with previously treated advanced hepatocellular carcinoma: a multicentre, open-label, parallel-group, randomised, phase 2 trial
DOI
doi.org/10.1016/s1470-2045(20)30011-5
Published Date
Feb 26, 2020
Journal
The Lancet Oncology
Volume
21
Issue
4
Pages
571 - 580
© 2025 Pluto Labs All rights reserved.